The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index; none of the 41 sources its claims cite is checked for support yet.
Replication of Genome-Wide Association Signals in UK Samples Reveals Risk Loci for Type 2 Diabetes
Open accessAbstract
The molecular mechanisms involved in the development of type 2 diabetes are poorly understood. Starting from genome-wide genotype data for 1924 diabetic cases and 2938 population controls generated by the Wellcome Trust Case Control Consortium, we set out to detect replicated diabetes association signals through analysis of 3757 additional cases and 5346 controls and by integration of our findings with equivalent data from other international consortia. We detected diabetes susceptibility loci in and around the genes CDKAL1 , CDKN2A/CDKN2B , and IGF2BP2 and confirmed the recently described associations at HHEX/IDE and SLC30A8 . Our findings provide insight into the genetic architecture of type 2 diabetes, emphasizing the contribution of multiple variants of modest effect. The regions identified underscore the importance of pathways influencing pancreatic beta cell development and function in the etiology of type 2 diabetes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 of 41 cited sources checked · 0 supported · 0 flagged
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Replication was also obtained for SNPs within the CDKAL1 locus on chromosome 6, including rs9465871 and rs10946398.”
§ Multiple type 2 diabetes susceptibility genes following genome-wide association scan in UK samples > Abstract
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The replication signal at rs10946398 was more striking (OR 1.14 [1.07-1.22], p=8.4×10−5) (Tables 1, S2).”
§ Multiple type 2 diabetes susceptibility genes following genome-wide association scan in UK samples > Abstract
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Rs8050136 (mapping to the FTO [fat mass associated with obesity] gene region on chr16) was among a cluster of SNPs generating the strongest evidence for association outside TCF7L2 in the original scan (risk allele OR 1.27 [1.16-1.37] p=2.0×10−8) (Figure S1).”
§ Multiple type 2 diabetes susceptibility genes following genome-wide association scan in UK samples > Abstract
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Genotyping of 21 representative SNPs generated evidence of replication (p<0.05) for three of these 9 regions (Tables 1, S2).”
§ Multiple type 2 diabetes susceptibility genes following genome-wide association scan in UK samples > Abstract
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesNone of the sources cited for this claim could be matched to a paper in Crossref, so there is nothing to check it against.
In the paper
“Here, we describe how integration of data from the WTCCC scan and our own replication studies with similar information generated by the Diabetes Genetics Initiative [DGI] (6) and the Finland-United States Investigation of NIDDM Genetics [FUSION] (7) has identified several additional susceptibility variants for T2D.”
§ Multiple type 2 diabetes susceptibility genes following genome-wide association scan in UK samples > Abstract
What the sources say
- Not matchedcites [6] Diabetes Genetics Initiative Science this issue
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matchedcites [7] Scott LJ Science this issue
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- Rests on an assumption: The DGI and FUSION genome-wide association data are comparable enough to the WTCCC and UK replication data to be combined in meta-analysis.
- Not matched
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“All associated SNPs map to a large (90kb) intron within CDKAL1 (Figure 1).”
§ Multiple type 2 diabetes susceptibility genes following genome-wide association scan in UK samples > Abstract
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“This SNP showed strong replication (OR 1.22 [1.12-1.32], p=5.4×10−7).”
§ Multiple type 2 diabetes susceptibility genes following genome-wide association scan in UK samples > Abstract
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesThe paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Across all studies, combined evidence for association at CDKAL1 is compelling (p~4.1×10−11).”
§ Multiple type 2 diabetes susceptibility genes following genome-wide association scan in UK samples > Abstract
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- Rests on an assumption: The DGI and FUSION genome-wide association data are comparable enough to the WTCCC and UK replication data to be combined in meta-analysis.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The third replicated association maps to the HHEX (homeobox, hematopoietically expressed) gene region on chromosome 10.”
§ Multiple type 2 diabetes susceptibility genes following genome-wide association scan in UK samples > Abstract
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The 3′ signal maps to sequence with no characterized genes, while the recombination interval enclosing the 5′ signal includes the full coding sequences of CDKN2B and CDKN2A (encoding p15INK4b and p16INK4a respectively).”
§ Multiple type 2 diabetes susceptibility genes following genome-wide association scan in UK samples > Abstract
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes
- It may state two separate claims as one. 23
- Probably not a substantial claim. 5
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We have detected expression of CDKAL1 mRNA in human pancreatic islet and skeletal muscle (Figure S2).”
§ Multiple type 2 diabetes susceptibility genes following genome-wide association scan in UK samples > Abstract
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We detected diabetes susceptibility loci in and around the genes CDKAL1, CDKN2A/CDKN2B and IGF2BP2 and confirmed the recently described associations at HHEX/IDE and SLC30A8.”
§ Multiple type 2 diabetes susceptibility genes following genome-wide association scan in UK samples > Abstract
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Although rs9465871 generated the stronger signal in the WTCCC scan, replication at this SNP was modest (p=0.023).”
§ Multiple type 2 diabetes susceptibility genes following genome-wide association scan in UK samples > Abstract
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“A second signal from the WTCCC scan located ~100kb 5′ (rs564398, OR 1.16 [1.07-1.27], p=3.2×10−4) was weakly supported in the FUSION, but not the DGI scan (Tables 1, S3) and replicated in the UK RS samples (OR 1.12 [1.05-1.19], p=8.6×10−4) (Tables 1, S3).”
§ Multiple type 2 diabetes susceptibility genes following genome-wide association scan in UK samples > Abstract
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- Rests on an assumption: The DGI and FUSION genome-wide association data are comparable enough to the WTCCC and UK replication data to be combined in meta-analysis.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Both DGI and FUSION studies showed modest, but consistent association signals generating strong combined evidence (p~5.7×10−10) for a role in T2D susceptibility (Tables 1, S3).”
§ Multiple type 2 diabetes susceptibility genes following genome-wide association scan in UK samples > Abstract
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- Rests on an assumption: The DGI and FUSION genome-wide association data are comparable enough to the WTCCC and UK replication data to be combined in meta-analysis.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“However, we genotyped rs13266634 independently and obtained replication of the finding (risk allele OR 1.12 [1.05-1.18], p=7.0×10−5 in all UK data) and across all three studies (p~5.3×10−8, Tables 1, S4).”
§ Multiple type 2 diabetes susceptibility genes following genome-wide association scan in UK samples > Abstract
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- Rests on an assumption: The DGI and FUSION genome-wide association data are comparable enough to the WTCCC and UK replication data to be combined in meta-analysis.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Of the remaining regions selected in the first wave, none showed any evidence of replication in UK samples (Table S2), and for none was there strong support from the DGI and FUSION scans.”
§ Multiple type 2 diabetes susceptibility genes following genome-wide association scan in UK samples > Abstract
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Evidence for association in the WTCCC scan (OR 1.16 [1.06-1.27], p=8.6×10−4) is supported by nominal replication in UK samples (1.08 [1.01-1.15], p=0.03) and by DGI scan results (1.17 [1.04-1.32], p=4.4×10−3).”
§ Multiple type 2 diabetes susceptibility genes following genome-wide association scan in UK samples > Abstract
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
- Rests on an assumption: The DGI and FUSION genome-wide association data are comparable enough to the WTCCC and UK replication data to be combined in meta-analysis.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Replication was observed in UK samples (rs10811661:OR 1.18 [1.08-1.28], p=1.7×10−4), as well as DGI (p=2.2×10−5) and FUSION follow-up studies (rs2383208, p=9.7×10−3).”
§ Multiple type 2 diabetes susceptibility genes following genome-wide association scan in UK samples > Abstract
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- Rests on an assumption: The DGI and FUSION genome-wide association data are comparable enough to the WTCCC and UK replication data to be combined in meta-analysis.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Both CDKN2B and CDKN2A display high levels of expression in pancreatic islets and pituitary (Figure S2).”
§ Multiple type 2 diabetes susceptibility genes following genome-wide association scan in UK samples > Abstract
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“As a result of the four GWA studies reported to date (5, 6, 7, 10), the number of genuine, replicated T2D susceptibility signals has climbed from 3 to 9 (adding HHEX/IDE, SLC30A8, CDKAL1, CDKN2A, IGF2BP2 and FTO).”
§ Multiple type 2 diabetes susceptibility genes following genome-wide association scan in UK samples > Abstract
What the sources say
- Not matchedcites [5] Donnelly P the WTCCC, personal communication Data from the Wellcome Trust Case Control Consortium scan
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matchedcites [6] Diabetes Genetics Initiative Science this issue
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matchedcites [7] Scott LJ Science this issue
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not checked yetcites [10] Sladek R Nature 2007 445 881 885 17293876 source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- Not matched
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“However, these loci explain only a small proportion of the observed familiality (the sibling relative risk, λs, attributable to all loci in the UK samples is only ~1.07).”
§ Multiple type 2 diabetes susceptibility genes following genome-wide association scan in UK samples > Abstract
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“As we recently reported (9), this effect on T2D risk is mediated through a primary effect on adiposity, and adjustment for BMI abolishes the T2D association.”
§ Multiple type 2 diabetes susceptibility genes following genome-wide association scan in UK samples > Abstract
What the sources say
- Not matchedcites [9] Frayling TM Science Published online April 12 2007
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- Not matched
In the paper
“We considered only the 393,453 autosomal SNPs with minor allele frequency (MAF) exceeding 1% in both cases and controls and no extreme departure from Hardy Weinberg equilibrium (HWE) (p<10−4 in cases or controls) (8).”
§ Multiple type 2 diabetes susceptibility genes following genome-wide association scan in UK samples > Abstract
What the sources say
- Not checked yetcites [8] Materials and methods are available as supporting material on Science Online
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“we first submitted putative signals from the WTCCC study to additional quality control including cluster plot visualization and validation genotyping on a second platform (8).”
§ Multiple type 2 diabetes susceptibility genes following genome-wide association scan in UK samples > Abstract
What the sources say
- Not checked yetcites [8] Materials and methods are available as supporting material on Science Online
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim. It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“CDK5 has been implicated in the regulation of pancreatic beta cell function, through formation of p35/CDK5 complexes that downregulate insulin expression (11, 12).”
§ Multiple type 2 diabetes susceptibility genes following genome-wide association scan in UK samples > Abstract
What the sources say
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“analysis of 490,032 autosomal SNPs in 16,179 samples yielded 459,448 SNPs that passed initial quality control (5).”
§ Multiple type 2 diabetes susceptibility genes following genome-wide association scan in UK samples > Abstract
What the sources say
- Not checked yetcites [5] Donnelly P the WTCCC, personal communication Data from the Wellcome Trust Case Control Consortium scan
Strength:plain· not yet calibratedn = 16,179Tests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The other three loci (near CDKAL1, IGF2BP2 and CDKN2A), all showing extensive replication across the three studies represent novel T2D susceptibility loci.”
§ Multiple type 2 diabetes susceptibility genes following genome-wide association scan in UK samples > Abstract
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Robust identification of variants with such effect sizes is only feasible with large-scale sample sets (13,965 individuals were typed in the present study).”
§ Multiple type 2 diabetes susceptibility genes following genome-wide association scan in UK samples > Abstract
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“Cdkn2b overexpression is also causally related to islet hypoplasia and diabetes in murine models (23).”
§ Multiple type 2 diabetes susceptibility genes following genome-wide association scan in UK samples > Abstract
What the sources say
- Not checked yetcites [23] Moritani M Mol. Cell Endocrinol 2005 229 175 184 15607541 source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The relatively strict thresholds imposed for SNP selection in the first wave (i.e. point-wise p<10−5) help to limit false discovery, but many genuine susceptibility variants will fail to reach them.”
§ Multiple type 2 diabetes susceptibility genes following genome-wide association scan in UK samples > Abstract
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“and is a powerful biological candidate (13, 14).”
§ Multiple type 2 diabetes susceptibility genes following genome-wide association scan in UK samples > Abstract
What the sources say
Strength:boosted· not yet calibratedTests✓ Asserted: passes✗ Checkable: fails✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. It may be too vague to check against evidence. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“CDKN2A is a known tumour suppressor and its product, p16INK4a, inhibits CDK4 (cyclin-dependent kinase 4), a powerful regulator of pancreatic beta cell replication (19-21).”
§ Multiple type 2 diabetes susceptibility genes following genome-wide association scan in UK samples > Abstract
What the sources say
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“While no signal is apparent in the FUSION study, this does not allow us to reject this association.”
§ Multiple type 2 diabetes susceptibility genes following genome-wide association scan in UK samples > Abstract
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“For 80% power to detect an OR of 1.11 (α=0.05), over 3,000 case-control pairs are needed.”
§ Multiple type 2 diabetes susceptibility genes following genome-wide association scan in UK samples > Abstract
Strength:plain· not yet calibratedn = 3,000Tests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“It also generates insights into T2D pathogenesis emphasizing the likely importance of pathways involved in pancreatic beta cell development, regeneration and function.”
§ Multiple type 2 diabetes susceptibility genes following genome-wide association scan in UK samples > Abstract
Load-bearingStrength:hedged· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Our study provides an important validation of the genome-wide indirect association mapping approach and a demonstration of the value of aggressive data sharing efforts.”
§ Multiple type 2 diabetes susceptibility genes following genome-wide association scan in UK samples > Abstract
Load-bearingStrength:boosted· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
The paper relies on this without support.
The DGI and FUSION genome-wide association data are comparable enough to the WTCCC and UK replication data to be combined in meta-analysis.
“integration of data from the WTCCC scan and our own replication studies with similar information generated by the Diabetes Genetics Initiative [DGI] (6) and the Finland-United States Investigation of NIDDM Genetics [FUSION] (7)”
“Across all studies, combined evidence for association at CDKAL1 is compelling (p~4.1×10−11).”
The paper relies on this without support.
The replication sets RS1-RS3 are independent of the WTCCC samples and free from population stratification that would bias replication.
“we attempted replication of selected signals in up to 3,757 additional cases and 5,346 controls (replication sets RS1-RS3).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These studies identified single-nucleotide polymorphisms (SNPs) in the second intron of the IGF2BP2 gene, particularly rs4402960 and rs1470579, as being significantly associated with an increased risk of T2D across various populations.”
From IMPlications of IMP2 in RNA Biology and Disease (2025) · cites this paper as [71]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“This idea, combined with the development of efficient methods for surveying large numbers of SNPs, has led to the many recent genome-wide association (GWA) studies that have detected SNPs that are significantly associated with breast cancer79,80, colorectal cancer81,82, type 2 diabetes83–86 and heart disease87,88, among other diseases.”
From Linkage disequilibrium--understanding the evolutionary past and mapping the medical future. (2008) · cites this paper as [84]
The cited source says what the claim attributes to it.
In the citing paper
“The association between IMP2 and T2D was first identified through genome-wide association studies (GWAS) in 2007, with three independent research groups demonstrating a strong link between genetic variants in the IGF2BP2 gene and T2D risk [69,70,71].”
From IMPlications of IMP2 in RNA Biology and Disease (2025) · cites this paper as [71]
In the citing paper
“Strikingly, recent genome-wide association studies link the cyclin-dependent kinase inhibitors CDKN2A and CDKN2B (encoding p15Ink4b) and the cell cycle regulators CDC123 and CDKAL1 to the risk of type 2 diabetes [34–37].”
From Expansion of β-cell mass in response to pregnancy (2010) · cites this paper as [34]
In the citing paper
“The product of the Ink4a/Arf (Cdkn2a) locus, p16Ink4a (a negative regulator of CDK4 D-type cyclins), is thought to be involved in aging, and in genome-wide studies it has linked with type 2 diabetes (35,36).”
From Age-Dependent Decline in β-Cell Proliferation Restricts the Capacity of β-Cell Regeneration in Mice (2009) · cites this paper as [35]
In the citing paper
“Interestingly, several of the recently discovered risk loci for type 2 diabetes have been implicated in cell cycle control of β-cells and could theoretically influence adult β-cell mass or alter the timing of cell cycle exit of adult β-cells (36–39).”
From Adaptive β-Cell Proliferation Is Severely Restricted With Advanced Age (2009) · cites this paper as [37]
In the citing paper
“2) Most associations do not involve previous candidate genes. In some cases, GWAS results immediately suggest new biological hypotheses— for example, the role of complement factor H in age-related macular degeneration (77–79), FGFR2 in breast cancer (98), and CDKN2A and CDKN2B in T2D (99–101).”
From Genetic Mapping in Human Disease (2008) · cites this paper as [99]
In the citing paper
“Examples include the region at 8q24 associated with prostate, breast, and colon cancer, 300 kb from the nearest gene (103, 104), and the region at 9q21 associated with myocardial infarction and T2D, 150 kb from the nearest genes encoding CDKN2A and CDKN2B (99–101, 105–107).”
From Genetic Mapping in Human Disease (2008) · cites this paper as [99]
In the citing paper
“5) Some regions reveal surprising associations. For example, unexpected connections have emerged among T2D, inflammatory diseases (two loci), and cancer (four loci). A single intron of CDKAL1 was found to contain a SNP associated with T2D and insulin secretion defects (99–101, 116), and another with Crohn’s disease and psoriasis (117).”
From Genetic Mapping in Human Disease (2008) · cites this paper as [99]
Citations
Cites
A haplotype map of the human genome
The International HapMap Consortium (2005) · Nature · doi:10.1038/nature04226 · Cited by 5,858
Frayling, T. M., Timpson, N. J., Weedon, M. N., Zeggini, E., Freathy, R. M., Lindgren, C. M., Perry, J. R. B., Elliott, K. S., Lango, H., Rayner, N. W., et al. (2007) · Science · doi:10.1126/science.1141634 · Cited by 4,531
Self-citationA genome-wide association study identifies novel risk loci for type 2 diabetes
Sladek, R., Rocheleau, G., Rung, J., Dina, C., Shen, L., Serre, D., Boutin, P., Vincent, D., Belisle, A., Hadjadj, S., et al. (2007) · Nature · doi:10.1038/nature05616 · Cited by 2,993
Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels
Saxena, R., Voight, B. F., Lyssenko, V., Burtt, N. P., de Bakker, P. I. W., Chen, H., Roix, J. J., Kathiresan, S., Hirschhorn, J. N., Daly, M. J., et al. (2007) · Science · doi:10.1126/science.1142358 · Cited by 2,843
A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants
Scott, L. J., Mohlke, K. L., Bonnycastle, L. L., Willer, C. J., Li, Y., Duren, W. L., Erdos, M. R., Stringham, H. M., Chines, P. S., Jackson, A. U., et al. (2007) · Science · doi:10.1126/science.1142382 · Cited by 2,753
Type 2 diabetes: principles of pathogenesis and therapy
Stumvoll, M., Goldstein, B. J., & van Haeften, T. W. (2005) · The Lancet · doi:10.1016/s0140-6736(05)61032-x · Cited by 2,662
Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes
Grant, S. F. A., Thorleifsson, G., Reynisdottir, I., Benediktsson, R., Manolescu, A., Sainz, J., Helgason, A., Stefansson, H., Emilsson, V., Helgadottir, A., et al. (2006) · Nature Genetics · doi:10.1038/ng1732 · Cited by 2,287
The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes
Altshuler, D., Hirschhorn, J. N., Klannemark, M., Lindgren, C. M., Vohl, M.-C., Nemesh, J., Lane, C. R., Schaffner, S. F., Bolk, S., Brewer, C., et al. (2000) · Nature Genetics · doi:10.1038/79216 · Cited by 1,766
Self-citationAligning Multiple Genomic Sequences With the Threaded Blockset Aligner
Blanchette, M., Kent, W. J., Riemer, C., Elnitski, L., Smit, A. F. A., Roskin, K. M., Baertsch, R., Rosenbloom, K., Clawson, H., Green, E. D., et al. (2004) · Genome Research · doi:10.1101/gr.1933104 · Cited by 1,452
A Fine-Scale Map of Recombination Rates and Hotspots Across the Human Genome
Myers, S., Bottolo, L., Freeman, C., McVean, G., & Donnelly, P. (2005) · Science · doi:10.1126/science.1117196 · Cited by 1,134
Flagged first, then by citations
Research works printed but not linked: 1
- Wellcome Trust Case Control Consortium Nature in press.
Cited by
Sorted by citations
Items 201–300 of 1,004
Recent progress in genetic and epigenetic research on type 2 diabetes
Kwak, S. H., & Park, K. S. (2016) · Experimental & Molecular Medicine · doi:10.1038/emm.2016.7 · Cited by 228
Riley, B. P., Thiselton, D. L., Maher, B. S., Bigdeli, T., Wormley, B., McMichael, G. O., Fanous, A. H., Vladimirov, V. I., O’Neill, F. A., Walsh, D., et al. (2009) · Molecular Psychiatry · doi:10.1038/mp.2009.109 · Cited by 224
Long non-coding RNAs as regulators of the endocrine system
Knoll, M., Lodish, H. F., & Sun, L. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.229 · Cited by 226
Chang, Y., Liu, P., Lee, W., Chang, T., Jiang, Y., Li, H., Kuo, S., Lee, K.-C., & Chuang, L. (2008) · Diabetes · doi:10.2337/db08-0377 · Cited by 224
TCF7L2 is a master regulator of insulin production and processing
Zhou, Y., Park, S.-Y., Su, J., Bailey, K. A., Ottosson-Laakso, E., Shcherbina, L., Oskolkov, N., Zhang, E., Thevenin, T., Fadista, J., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu359 · Cited by 217
Sequence variants on chromosome 9p21.3 confer risk for atherosclerotic stroke
Gschwendtner, A., Bevan, S., Cole, J. W., Plourde, A., Matarín, M., Ross‐Adams, H., Meitinger, T., Wichmann, E., Mitchell, B. D., Furie, K. L., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21590 · Cited by 217
Radical S-Adenosylmethionine Enzymes in Human Health and Disease
Landgraf, B. J., McCarthy, E. L., & Booker, S. J. (2016) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060713-035504 · Cited by 214
A Genome-Wide Association Study of Optic Disc Parameters
Ramdas, W. D., van Koolwijk, L. M. E., Ikram, M. K., Jansonius, N. M., de Jong, P. T. V. M., Bergen, A. A. B., Isaacs, A. J., Amin, N., Aulchenko, Y. S., Wolfs, R. C. W., et al. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1000978 · Cited by 213
Bochenek, G., Häsler, R., Mokhtari, N. E. E., König, I. R., Loos, B. G., Jepsen, S., Rosenstiel, P. C., Schreiber, S., & Schäefer, A. S. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt299 · Cited by 218
Browning, B. L., & Yu, Z. (2009) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2009.11.004 · Cited by 217
Identification of New Genetic Risk Variants for Type 2 Diabetes
Shu, X. O., Long, J., Cai, Q., Qi, L., Xiang, Y., Cho, Y. S., Tai, E. S., Li, X., Xu, L., Chow, W., et al. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1001127 · Cited by 212
Cupples, L. A., Arruda, H. T., Benjamin, E. J., D’Agostino, R. B., Demissie, S., DeStefano, A. L., Dupuis, J., Falls, K. M., Fox, C. S., Gottlieb, D. J., et al. (2007) · BMC Medical Genetics · doi:10.1186/1471-2350-8-s1-s1 · Cited by 213
Ragvin, A., Moro, E., Fredman, D., Navratilova, P., Drivenes, Ø., Engström, P. G., Alonso, M. E., Mustienes, E. D. L. C., Skarmeta, J. L. G., Tavares, M. J., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911591107 · Cited by 211
Horikoshi, M., Hara, K., Ito, C., Shojima, N., Nagai, R., Ueki, K., Froguel, P., & Kadowaki, T. (2007) · Diabetologia · doi:10.1007/s00125-007-0827-5 · Cited by 211
Raelson, J., Little, R. D., Ruether, A., Fournier, H., Paquin, B., Eerdewegh, P. V., Bradley, W. E. C., Croteau, P., Nguyen-Huu, Q., Segal, J. P., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706645104 · Cited by 211
Genomics and Genetics in the Biology of Adaptation to Exercise
Bouchard, C., Rankinen, T., & Timmons, J. A. (2011) · Comprehensive physiology · doi:10.1002/cphy.c100059 · Cited by 222
Polycystic ovary syndrome in adolescents
Franks, S. (2008) · International Journal of Obesity · doi:10.1038/ijo.2008.61 · Cited by 210
The Pathophysiology of Hyperglycemia in Older Adults: Clinical Considerations
Lee, P., & Halter, J. B. (2017) · Diabetes Care · doi:10.2337/dc16-1732 · Cited by 226
Gene-Diet Interaction and Precision Nutrition in Obesity
Heianza, Y., & Qi, L. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18040787 · Cited by 222
The InterAct Consortium (2011) · Diabetologia · doi:10.1007/s00125-011-2182-9 · Cited by 208
mTOR phosphorylates IMP2 to promote IGF2 mRNA translation by internal ribosomal entry
Dai, N., Rapley, J., Angel, M., Yanik, M. F., Blower, M. D., & Avruch, J. (2011) · Genes & Development · doi:10.1101/gad.2042311 · Cited by 208
Molecular genetics of Alzheimer's disease: An update
Brouwers, N., Sleegers, K., & Broeckhoven, C. V. (2008) · Annals of Medicine · doi:10.1080/07853890802186905 · Cited by 213
Chen, D. T., Jiang, X., Akula, N., Shugart, Y. Y., Wendland, J. R., Steele, C. J. M., Kassem, L., Park, J.-H., Chatterjee, N., Jamain, S., et al. (2011) · Molecular Psychiatry · doi:10.1038/mp.2011.157 · Cited by 220
The HapMap and Genome-Wide Association Studies in Diagnosis and Therapy
Manolio, T. A., & Collins, F. S. (2009) · Annual Review of Medicine · doi:10.1146/annurev.med.60.061907.093117 · Cited by 210
TCF7L2 Regulates Late Events in Insulin Secretion From Pancreatic Islet β-Cells
Xavier, G. D. S., Loder, M. K., McDonald, A., Tarasov, A. I., Carzaniga, R., Kronenberger, K., Barg, S., & Rutter, G. A. (2009) · Diabetes · doi:10.2337/db08-1187 · Cited by 209
ANRIL: A lncRNA at the CDKN2A/B Locus With Roles in Cancer and Metabolic Disease
Kong, Y., Hsieh, C.-H., & Alonso, L. C. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00405 · Cited by 216
Learning your identity and disease from research papers
Wang, R., Li, Y. F., Wang, X., Tang, H., & Zhou, X. (2009) · ACM SIGSAC Conference on Computer and Communications Security (CCS) · doi:10.1145/1653662.1653726 · Cited by 209
Wenzlau, J. M., Liu, Y., Yu, L., Moua, O., Fowler, K. T., Rangasamy, S., Walters, J., Eisenbarth, G. S., Davidson, H. W., & Hutton, J. C. (2008) · Diabetes · doi:10.2337/db08-0522 · Cited by 205
Methods for meta-analysis in genetic association studies: a review of their potential and pitfalls
Kavvoura, F. K., & Ioannidis, J. P. A. (2007) · Human Genetics · doi:10.1007/s00439-007-0445-9 · Cited by 209
Epigenetic regulation of the INK4b-ARF-INK4a locus: In sickness and in health
Popov, N., & Gil, J. (2010) · Epigenetics · doi:10.4161/epi.5.8.12996 · Cited by 202
Le‐Niculescu, H., Patel, S. D., Bhat, M., Kuczenski, R., Faraone, S. V., Tsuang, M. T., McMahon, F. J., Schork, N. J., Nurnberger, J. I., & Niculescu, A. B. (2009) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30887 · Cited by 201
Tbc1d1 mutation in lean mouse strain confers leanness and protects from diet-induced obesity
Chadt, A., Leicht, K., Deshmukh, A. S., Jiang, L. Q., Scherneck, S., Bernhardt, U., Dreja, T., Vogel, H., Schmolz, K., Kluge, R., et al. (2008) · Nature Genetics · doi:10.1038/ng.244 · Cited by 201
FTO gene variants are strongly associated with type 2 diabetes in South Asian Indians
Yajnik, C. S., Janipalli, C. S., Bhaskar, S., Kulkarni, S. R., Freathy, R. M., Prakash, S. S., Mani, K. R., Weedon, M. N., Kale, S. D., Deshpande, J., et al. (2008) · Diabetologia · doi:10.1007/s00125-008-1186-6 · Cited by 200
Self-citationDayeh, T. A., Olsson, A. H., Volkov, P., Almgren, P., Rönn, T., & Ling, C. (2013) · Diabetologia · doi:10.1007/s00125-012-2815-7 · Cited by 199
Grant, S. F. A., Li, M., Bradfield, J. P., Kim, C., Annaiah, K., Santa, E., Glessner, J., Casalunovo, T., Frackelton, E. C., Otieno, F. G., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001746 · Cited by 206
Autoantibodies to zinc transporter 8 and SLC30A8 genotype stratify type 1 diabetes risk
Achenbach, P., Lampasona, V., Landherr, U., Koczwara, K., Krause, S. W., Grallert, H., Winkler, C., Pflüger, M., Illig, T., Bonifacio, E. E., et al. (2009) · Diabetologia · doi:10.1007/s00125-009-1438-0 · Cited by 197
Type 2 diabetes: new genes, new understanding
Prokopenko, I., McCarthy, M. I., & Lindgren, C. M. (2008) · Trends in Genetics · doi:10.1016/j.tig.2008.09.004 · Cited by 254
Self-citationMaternal nutrition, intrauterine programming and consequential risks in the offspring
Yajnik, C. S., & Deshmukh, U. (2008) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-008-9087-z · Cited by 194
Shen, G.-Q., Li, L., Rao, S., Abdullah, K. G., Ban, J. M., Lee, B.-S., Park, J. E., & Wang, Q. K. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.157248 · Cited by 195
SNP Selection in genome‐wide and candidate gene studies via penalized logistic regression
Ayers, K. L., & Cordell, H. J. (2010) · Genetic Epidemiology · doi:10.1002/gepi.20543 · Cited by 201
Waters, K. M., Stram, D. O., Hassanein, M. T., Le Marchand, L., Wilkens, L. R., Maskarinec, G., Monroe, K. R., Kolonel, L. N., Altshuler, D., Henderson, B. E., et al. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1001078 · Cited by 191
Ling, C., Poulsen, P., Simonsson, S., Rönn, T., Holmkvist, J., Almgren, P., Hagert, P., Nilsson, E., Mabey, A. G., Nilsson, P. M., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30938 · Cited by 195
Chang, Y., Chang, T., Jiang, Y., Kuo, S., Lee, K., Chiu, K. C., & Chuang, L. (2007) · Diabetes · doi:10.2337/db07-0421 · Cited by 191
Using genome‐wide pathway analysis to unravel the etiology of complex diseases
Elbers, C. C., van Eijk, K. R., Franke, L., Mulder, F., van der Schouw, Y. T., Wijmenga, C., & Onland‐Moret, N. C. (2009) · Genetic Epidemiology · doi:10.1002/gepi.20395 · Cited by 192
Dai, N., Zhao, L., Wrighting, D., Krämer, D., Majithia, A., Wang, Y., Cracan, V., Borges-Rivera, D., Mootha, V. K., Nahrendorf, M., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.03.006 · Cited by 188
Missing data imputation and haplotype phase inference for genome-wide association studies
Browning, S. R. (2008) · Human Genetics · doi:10.1007/s00439-008-0568-7 · Cited by 196
FTO and Obesity: Mechanisms of Association
Zhao, X., Yang, Y., Sun, B.-F., Zhao, Y.-L., & Yang, Y. (2014) · Current Diabetes Reports · doi:10.1007/s11892-014-0486-0 · Cited by 193
An Ancient Evolutionary Origin of Genes Associated with Human Genetic Diseases
Domazet‐Lošo, T., & Tautz, D. (2008) · Molecular Biology and Evolution · doi:10.1093/molbev/msn214 · Cited by 193
Holdt, L. M., & Teupser, D. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.232678 · Cited by 191
Qi, L., Cornelis, M. C., Kraft, P. L., Jensen, M. K., van Dam, R. M., Sun, Q., Girman, C. J., Laurie, C. C., Mirel, D. B., Hunter, D. J., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq057 · Cited by 188
Little, J., Higgins, J. P. T., Ioannidis, J. P. A., Moher, D., Gagnon, F., von Elm, E. B., Khoury, M. J., Cohen, B. J., Smith, G. D., Grimshaw, J., et al. (2009) · Human Genetics · doi:10.1007/s00439-008-0592-7 · Cited by 185
Chauhan, G., Spurgeon, C. J., Tabassum, R., Bhaskar, S., Kulkarni, S. R., Mahajan, A., Chavali, S., Kumar, M. V. K., Prakash, S., Dwivedi, O. P., et al. (2010) · Diabetes · doi:10.2337/db09-1386 · Cited by 189
Anderson, C. A., Massey, D. C. O., Barrett, J. C., Prescott, N. J., Tremelling, M., Fisher, S. A., Gwilliam, R., Jacob, J., Nimmo, E. R., Drummond, H. E., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.10.032 · Cited by 185
Self-citationLanders, J. E., Melki, J., Meininger, V., Glass, J. D., van den Berg, L. H., van Es, M. A., Sapp, P. C., van Vught, P. W. J., McKenna-Yasek, D. M., Blauw, H. M., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812937106 · Cited by 190
Xia, Q., & Grant, S. F. A. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12020 · Cited by 191
IGF2 mRNA-binding protein 2: biological function and putative role in type 2 diabetes
Christiansen, J., Kolte, A. M., Hansen, T. V. O., & Nielsen, F. C. (2009) · Journal of Molecular Endocrinology · doi:10.1677/jme-09-0016 · Cited by 188
The pursuit of genome-wide association studies: where are we now?
Ku, C., Loy, E. Y., Yudi Pawitan, Y., & Chia, K. S. (2010) · Journal of Human Genetics · doi:10.1038/jhg.2010.19 · Cited by 184
Sun, J., Cui, J., He, Q., Chen, Z., Arvan, P., & Liu, M. R. (2015) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2015.01.001 · Cited by 183
A Genome-Wide Association Study Identifies GRK5 and RASGRP1 as Type 2 Diabetes Loci in Chinese Hans
Li, H., Gan, W., Lu, L., Dong, X., Han, X., Hu, C., Yang, Z., Sun, L., Bao, W., Li, P., et al. (2012) · Diabetes · doi:10.2337/db12-0454 · Cited by 182
Hu, C., Zhang, R., Wang, C., Wang, J., Ma, X., Lu, J., Qin, W., Hou, X., Wang, C., Bao, Y., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007643 · Cited by 178
Pendergrass, S. A., Brown-Gentry, K. D., DUDEK, S. M., Frase, A., Torstenson, E. S., Goodloe, R., Ambite, J. L., Avery, C. L., Buyske, S. G., Bůžková, P., et al. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003087 · Cited by 181
Wolfson, M. C., Wallace, S. E., Masca, N. G. D., Rowe, G., Sheehan, N. A., Ferretti, V., Laflamme, P., Tobin, M. D., Macleod, J., Little, J., et al. (2010) · International Journal of Epidemiology · doi:10.1093/ije/dyq111 · Cited by 190
Variations in the G6PC2/ABCB11 genomic region are associated with fasting glucose levels
Chen, W., Erdos, M. R., Jackson, A., Saxena, R., Sanna, S., Silver, K. D., Timpson, N. J., Hansen, T. F., Orrù, M., Piras, M. G., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34566 · Cited by 179
Self-citationOlsson, A. H., Volkov, P., Bacos, K., Dayeh, T., Hall, E., Nilsson, E., Ladenvall, C., Rönn, T., & Ling, C. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004735 · Cited by 186
Inflammatory mechanisms linking periodontal diseases to cardiovascular diseases
Schenkein, H. A., & Loos, B. G. (2013) · Journal of Periodontology · doi:10.1902/jop.2013.134006 · Cited by 181
Genetics of type 2 diabetes: pathophysiologic and clinical relevance
Herder, C., & Roden, M. (2010) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2010.02454.x · Cited by 187
Pharmacogenetics in drug discovery and development: a translational perspective
Roses, A. D. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2593 · Cited by 177
A Central Role for GRB10 in Regulation of Islet Function in Man
Prokopenko, I., Poon, W., Mägi, R., Prasad, R. B., Salehi, A. A., Almgren, P., Osmark, P., Bouatia‐Naji, N., Wierup, N., Fall, T., et al. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004235 · Cited by 176
Self-citationLncRNAs in vascular biology and disease
Simion, V., Haemmig, S., & Feinberg, M. W. (2018) · Vascular Pharmacology · doi:10.1016/j.vph.2018.01.003 · Cited by 174
Lee, Y., Kang, E. S., Kim, S. H., Han, S. J., Kim, C. H., Kim, H. J., Ahn, C. W., Soo, B., Nam, M., Nam, C. M., et al. (2008) · Journal of Human Genetics · doi:10.1007/s10038-008-0341-8 · Cited by 174
Swaroop, A., Branham, K. E., Chen, W., & Abecasis, G. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm212 · Cited by 173
Interpreting Meta-Analyses of Genome-Wide Association Studies
Han, B., & Eskin, E. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002555 · Cited by 177
Imamura, M., Takahashi, A., Yamauchi, T., Hara, K., Yasuda, K., Grarup, N., Zhao, W., Wang, X., Huerta‐Chagoya, A., Hu, C., et al. (2016) · Nature Communications · doi:10.1038/ncomms10531 · Cited by 176
Wolf, N., Quaranta, M., Prescott, N. J., Allen, M., Smith, R., Burden, A. D., Worthington, J., Griffiths, C. E. M., Mathew, C. G., Barker, J. N., et al. (2008) · Journal of Medical Genetics · doi:10.1136/jmg.2007.053595 · Cited by 171
Stančáková, A., Kuulasmaa, T., Paananen, J., Jackson, A., Bonnycastle, L. L., Collins, F. S., Boehnke, M., Kuusisto, J., & Laakso, M. (2009) · Diabetes · doi:10.2337/db09-0117 · Cited by 171
Sparsø, T., Andersen, G., Nielsen, T., Burgdorf, K. S., Gjesing, A. P., Nielsen, A. L., Albrechtsen, A., Rasmussen, S. S., Jørgensen, T., Borch‐Johnsen, K., et al. (2007) · Diabetologia · doi:10.1007/s00125-007-0865-z · Cited by 171
Prevention of Diabetes and Cardiovascular Disease in Obesity
Sala, L. L., & Pontiroli, A. E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218178 · Cited by 179
Little, J., Higgins, J. P. T., Ioannidis, J. P. A., Moher, D., Gagnon, F., von Elm, E. B., Khoury, M. J., Cohen, B., Smith, G. D., Grimshaw, J., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-3-200902030-00011 · Cited by 172
Rampersaud, E., Damcott, C. M., Fu, M., Shen, H., McArdle, P., Shi, X., Shelton, J., Yin, J., Chang, Y.-P. C., Ott, S. H., et al. (2007) · Diabetes · doi:10.2337/db07-0457 · Cited by 170
Singapore Genome Variation Project: A haplotype map of three Southeast Asian populationsPreprint
Teo, Y., Sim, X., Ong, R. T., Tan, A. K. S., Chen, J., Tantoso, E., Small, K. S., Ku, C., Lee, E. J. D., Seielstad, M. T., et al. (2009) · Genome Research · doi:10.1101/gr.095000.109 · Cited by 173
Simultaneous and selective inference: Current successes and future challenges
Benjamini, Y. (2010) · Biometrical Journal · doi:10.1002/bimj.200900299 · Cited by 169
Latent autoimmune diabetes of the adult: current knowledge and uncertainty
Laugesen, E., Østergaard, J. A., & Leslie, R. D. (2015) · Diabetic Medicine · doi:10.1111/dme.12700 · Cited by 175
Disruptive insights in psychiatry: transforming a clinical discipline
Insel, T. R. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38832 · Cited by 172
Matarín, M., Brown, W. M., Singleton, A., Hardy, J., & Meschia, J. F. (2008) · Stroke · doi:10.1161/strokeaha.107.502963 · Cited by 169
Deletion of the mouse Slc30a8 gene encoding zinc transporter-8 results in impaired insulin secretion
Pound, L. D., Sarkar, S. A., Benninger, R. K. P., Wang, Y., Suwanichkul, A., Shadoan, M. K., Printz, R. L., Oeser, J. K., Lee, C. E., Piston, D. W., et al. (2009) · Biochemical Journal · doi:10.1042/bj20090530 · Cited by 167
Vaxillaire, M., & Froguel, P. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0024 · Cited by 172
The Genetics of Autism: Key Issues, Recent Findings, and Clinical Implications
El-Fishawy, P., & State, M. W. (2010) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2009.12.002 · Cited by 166
Ahlqvist, E., Ahluwalia, T. S., & Groop, L. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2010.157016 · Cited by 166
Selective inference in complex research
Benjamini, Y., Heller, R., & Yekutieli, D. (2009) · Philosophical Transactions of the Royal Society A Mathematical Physical and Engineering Sciences · doi:10.1098/rsta.2009.0127 · Cited by 166
Genetics of type 2 diabetes: the GWAS era and future perspectives [Review]
Imamura, M., & Maeda, S. (2011) · Endocrine Journal · doi:10.1507/endocrj.ej11-0113 · Cited by 167
Polymorphisms within Novel Risk Loci for Type 2 Diabetes Determine β-Cell Function
Staiger, H., Machicao, F. E., Stefan, N., Tschritter, O., Thamer, C., Kantartzis, K., Schäfer, S., Kirchhoff, K., Fritsche, A., & Häring, H. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000832 · Cited by 166
Rare and Common Genetic Events in Type 2 Diabetes: What Should Biologists Know?
Bonnefond, A., & Froguel, P. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2014.12.020 · Cited by 174
Cauchi, S., Meyre, D., Durand, E., Cavalcanti-Proença, C., Marre, M., Hadjadj, S., Choquet, H., Graeve, F. D., Gaget, S., Allegaert, F., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002031 · Cited by 163
Gene–Environment Interactions in the Etiology of Obesity: Defining the Fundamentals
Bouchard, C. (2008) · Obesity · doi:10.1038/oby.2008.528 · Cited by 169
Genetic predisposition, Western dietary pattern, and the risk of type 2 diabetes in men
Qi, L., Cornelis, M. C., Zhang, C., van Dam, R. M., & Hu, F. B. (2009) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.27249 · Cited by 161
The genetics of autoimmune diseases: a networked perspective
Baranzini, S. E. (2009) · Current Opinion in Immunology · doi:10.1016/j.coi.2009.09.014 · Cited by 164
Brunner, E. J., Mika Kivimaki, B., Witte, D. R., Lawlor, D. A., Smith, G. D., Cooper, J. A., Miller, M. A., Lowe, G. D. O., Rumley, A., Casas, J. P., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050155 · Cited by 162
Self-citationCholesterol in islet dysfunction and type 2 diabetes
Brunham, L. R., Kruit, J. K., Verchere, C. B., & Hayden, M. R. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33296 · Cited by 158
Type 2 Diabetes Genetics: Beyond GWAS
Sanghera, D. K., & Blackett, P. R. (2012) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000198 · Cited by 167
Genetics of diabetes – Are we missing the genes or the disease?
Groop, L., & Pociot, F. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.04.002 · Cited by 168
Metadata
- Authors
- Zeggini, E., Weedon, M. N., Lindgren, C. M., Frayling, T. M., Elliott, K. S., Lango, H., Timpson, N. J., Perry, J. R. B., Rayner, N. W., Freathy, R. M., Barrett, J. C., Shields, B., Morris, A. P., Ellard, S., Groves, C. J., Harries, L. W., Marchini, J. L., Owen, K. R., Knight, B., Cardon, L. R., Walker, M., Hitman, G. A., Morris, A. D., Doney, A. S. F., McCarthy, M. I., & Hattersley, A. T.
- Affiliations
- Centre for Human Genetics (GB)
- Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Churchill Hospital, Oxford, OX3 7LJ, UK.
- Corresponding author
- Zeggini, Eleftheria
- Weedon, Michael N.
- Lindgren, Cecilia M.
- Frayling, Timothy M.
- McCarthy, Mark I.
- Hattersley, Andrew T.
- ORCID
- Zeggini, Eleftheria
- Weedon, Michael N.
- Lindgren, Cecilia M.
- Frayling, Timothy M.
- Elliott, Katherine S.
- Timpson, Nicholas J.
- Perry, John R. B.
- Freathy, Rachel M.
- Barrett, Jeffrey C.
- Shields, Beverley
- Morris, Andrew P.
- Ellard, Sian
- Harries, Lorna W.
- Marchini, Jonathan L.
- Owen, Katharine R.
- Walker, Mark
- Hitman, Graham A.
- Morris, Andrew D.
- Doney, Alex S. F.
- McCarthy, Mark I.
- Hattersley, Andrew T.
- Venue
- Science
- Published
- 2007-06
- Volume
- 316
- Issue
- 5829
- Pages
- 1336-1341
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC3772310
- OpenAlex
- W1944558458
- Semantic Scholar
- 3acd41eeafe82b68094fdf0a487d8781b01fb790
- Cited by
- 2,194
- References
- 24
- Citations by year
- 2026: 13 · 2025: 32 · 2024: 36 · 2023: 28 · 2022: 29 · 2021: 51 · 2020: 56 · 2019: 52 · 2018: 66 · 2017: 78 · 2016: 80 · 2015: 108 · 2014: 121 · 2013: 121 · 2012: 159
- FWCI
- 178.50
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Bristol Research (University of Bristol) (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Discovery Research Portal (University of Dundee) (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
- Research Portal (Queen's University Belfast) (submittedVersion)
- Explore Bristol Research (submittedVersion)
- UEA Digital Repository (University of East Anglia) (submittedVersion)
- Newcastle University ePrints (Newcastle Univesity)
- Funders
- Wellcome Trust (090532, 518153, 083948)
- Leverhulme Trust
- Diabetes UK
- Research Councils UK
- European Commission
- Medical Research Council (G0000934)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Mapping and Diversity in Plants and Animals
- Keywords
- type 2 diabetes, genetic susceptibility loci, CDKAL1, CDKN2A/CDKN2B, IGF2BP2, SLC30A8, beta-cell function, genetic architecture, Wellcome Trust Case Control Consortium
- MeSH terms
- Adult, Aged, Chromosome Mapping, Diabetes Mellitus, Type 2, Female, United Kingdom, Humans, Introns, Male, Middle Aged, Transcription Factors, Meta-Analysis as Topic, Genome, Human, Case-Control Studies, Homeodomain Proteins, Insulin-Like Growth Factor Binding Proteins, Genes, p16, Genetic Predisposition to Disease, Oligonucleotide Array Sequence Analysis, Polymorphism, Single Nucleotide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-06, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-06 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
